X hits on this document

159 views

0 shares

0 downloads

0 comments

21 / 49

Weintraub et al

Acute Heart Failure Syndromes

1995

16, 2009. doi:10.1016/j.ijcard.2009.03.005. Available at: http:// www.sciencedirect.com/science/journal/01675273.

  • 193.

    Lim TK, Ashrafian H, Dwivedi G, Collinson PO, Senior R. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: implication for diagnosis of diastolic heart failure. Eur J Heart Fail. 2006,8:38–45.

  • 194.

    Tripepi G, Mattace-Raso F, Mallamaci F, Benedetto FA, Witteman J, Malatino L, Zoccali C. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. Hypertension. 2009;54: 818 – 824.

  • 195.

    Adamopoulos C, Zannad F, Fay R, Mebazaa A, Cohen-Solal A, Guize L, Juilliere Y, Alla F. Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure. Eur J Heart Fail. 2007;9:935–941.

  • 196.

    Styron JF, Jois-Bilowich P, Starling R, Hobbs RE, Kontos MC, Pang PS, Peacock WF. Initial emergency department systolic blood pressure predicts left ventricular systolic function in acute decompensated heart failure. Congest Heart Fail. 2009;15:9–13.

  • 197.

    Uriel N, Torre-Amione G, Milo O, Kaluski E, Perchenet L, Blatt A, Kobrin I, Turnovski A, Kaplan S, Rainisio M, Frey A, Vered Z, Cotter

    • G.

      Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short-term outcome. Eur J Heart Fail. 2005;7:815–819.

  • 198.

    Allen LA, Hernandez AF, O’Connor CM, Felker GM. End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol. 2009;53:2248 –2258.

  • 199.

    Wuerz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med. 1992; 21:669 – 674.

  • 200.

    Peacock WF, Emerman C, Costanzo MR, Diercks DB, Lopatin M, Fonarow GC. Early vasoactive drugs improve heart failure outcomes. Congest Heart Fail. 2009;15:256–264.

  • 201.

    Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol. 2008;52:534–540.

  • 202.

    Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Fil- ippatos G, Gheorghiade M; Acute Heart Failure Syndromes Interna- tional Working Group. A proposal to standardize dyspnoea mea- surement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008;29:816–824.

  • 203.

    Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo- controlled, parallel-group, dose-finding phase IIb study. Lancet. 2009; 373:1429 –1439.

  • 204.

    Adams JKF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209–216.

  • 205.

    Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, Yancy CW, Young J. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148: 43–51.

  • 206.

    Diercks DB, Fonarow GC, Kirk JD, Emerman CL, Hollander JE, Weber JE, Summers RL, Wynne J, Peacock WF IV; ADHERE Scientific Advisory Committee and Investigators. Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM). Acad Emerg Med. 2008;15: 151–158.

  • 207.

    Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA; UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675–683.

  • 208.

    Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA; Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for

Acute Decompensated Heart Failure (UNLOAD) Investigators. Ultra- filtration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail. 2010;16:277–284.

  • 209.

    Beohar N, Erdogan AK, Lee DC, Sabbah HN, Kern MJ, Teerlink J, Bonow RO, Gheorghiade M. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol. 2008;52:13–16.

  • 210.

    Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, Liu PP, Konstam MA, Greenberg B, Mehra MR, Breithardt G, Pang PS, Young JB, Fonarow GC, Bonow RO, Gheorghiade M; Acute Heart Failure Syndromes International Working Group. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009;53:254–263.

  • 211.

    Pang PS, Komajda M, Gheorghiade M. The current and future man- agement of acute heart failure syndromes. Eur Heart J. 2010;31: 784 –793.

  • 212.

    Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R; Rapid Emergency Department Heart Failure Outpatient Trial investi- gators. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol. 2004;44:1328–1333.

  • 213.

    Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Pina IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O’Connor CM. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007;167:1998–2005.

  • 214.

    Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation. 2007;115:949–952.

  • 215.

    Yamokoski LM, Hasselblad V, Moser DK, Binanay C, Conway GA, Glotzer JM, Hartman KA, Stevenson LW, Leier CV. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail. 2007;13:8–13.

  • 216.

    Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Applications and methodological standards. N Engl J Med. 1985;313: 793–799.

  • 217.

    Wasson JH, Sox HC. Clinical prediction rules. Have they come of age? JAMA. 1996;275:641–642.

  • 218.

    Goldman L, Weinberg M, Weisberg M, Olshen R, Cook EF, Sargent RK, Lamas GA, Dennis C, Wilson C, Deckelbaum L, Fineberg H, Stiratelli R. A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med. 1982; 307:588 –596.

  • 219.

    Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277: 488 – 494.

  • 220.

    McCausland JB, Machi MS, Yealy DM. Emergency physicians’ risk attitudes in acute decompensated heart failure patients. Acad Emerg Med. 2010;17:108–110.

  • 221.

    Storrow AB, Collins S, Lindsell CJ, Disalvo T, Han J, Weintraub NL. Improving Heart Failure Risk Stratification in the ED: Stratify 1R01HL088459-01; Treatment Endpoints in Acute Decompensated Heart Failure 1K23HL085387-01A2. Vanderbilt University and Uni- versity of Cincinnati: National Heart, Lung, and Blood Institute; 2007.

  • 222.

    Tatum JL, Jesse RL, Kontos MC, Nicholson CS, Schmidt KL, Roberts CS, Ornato JP. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29:116–125.

  • 223.

    Gibler WB, Runyon JP, Levy RC, Sayre MR, Kacich R, Hattemer CR, Hamilton C, Gerlach JW, Walsh RA. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 1995;25:1–8.

  • 224.

    Storrow AB, Gibler WB. Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med. 2000;35:449–461.

  • 225.

    Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, Fine JM, Obrosky DS, Edick SM, Hough LJ, Tuozzo K, Fine MJ. The emergency department community-acquired pneumonia trial: meth- odology of a quality improvement intervention. Ann Emerg Med. 2004; 43:770 –782.

  • 226.

    Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community- acquired pneumonia. CAPITAL Study Investigators. Community- Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000;283:749 –755.

Downloaded from http://circ.ahajournals

.org/ by guest on February 5, 2015

Document info
Document views159
Page views159
Page last viewedSun Dec 11 12:19:18 UTC 2016
Pages49
Paragraphs1916
Words46879

Comments